Skip to main content
. 2021 Jan 27;25(4):319–326. doi: 10.5213/inj.2040364.182

Table 1.

Patient distribution according to diagnosis and the success rate of sacral nerve stimulation (positive response to acute and subacute stimulation proceeding to IPG implant)

Clinical diagnosis Patients undergoing acute nerve evaluation Patients undergoing subacute stimulation Patient receiving IPG (successful subacute stimulation)
OAB 36 (34) 32 (88.9) 20 (55.6)
UR 37 (34.9) 30 (81.1) 21 (56.8)
BPS/IC 19 (17.9) 17 (89.4) 12 (63.15)
FI 8 (7.5) 7 (87.5) 7 (87.5)
DI 6 (5.7) 5 (83.3) 4 (66.7)
Total 106 (100) 91 (85.9) 64 (60.4)

Values are presented as number (%).

IPG, implantable pulse generator; OAB, overactive bladder; UR, urinary retention; BPS/IC, bladder pain syndrome/interstitial cystitis; FI, fecal incontinence; DI, double incontinence.